Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics.

Martin, Kyle P; Grimaldi, Christine; Grempler, Rolf; Hansel, Steven; Kumar, Sandeep

Martin, Kyle P; Grimaldi, Christine; Grempler, Rolf; Hansel, Steven; Kumar, Sandeep.

Affiliation

Martin KP; Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT, USA.
Grimaldi C; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT, USA.
Grempler R; Clinical Pharmacology, Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT, USA.
Hansel S; Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT, USA.
Kumar S; Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT, USA.

MAbs ; 15(1): 2191301, 2023.

Article in En | MEDLINE | ID: mdl-36998195

Subject(s)

Industrial Development; Neoplasms; Humans; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal/pharmacology; Neoplasms/drug therapy; Injections, Subcutaneous

Key words

Antibody; biotherapeutics; developability; drug; formulation; pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Industrial Development / Neoplasms Limits: Humans Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google